Koerner M M, Durand J B, Lafuente J A, Noon G P, Torre-Amione G
Baylor College of Medicine, Houston, Texas 77030, USA.
Curr Opin Cardiol. 2000 May;15(3):178-82. doi: 10.1097/00001573-200005000-00010.
End-stage heart failure is still associated with a decrease in quality and prognosis of life. Cardiac transplantation remains the final extraordinary therapeutic option for the treatment of truly irreversible end-stage heart failure in all age groups. The selection process of candidates and the acceptance of patients with relative contra-indications is characterized by the experience and skills of an interdisciplinary transplant team, which should have access to different mechanical circulatory support systems for short-term or long-term use: bridging to transplant as well as for recovery.
